Liraglutide for Maturity-Onset Diabetes of the Young
Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)
Recruiting
Phase 2
Interventional Study
Maturity Onset Diabetes of the Young
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 10 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- Mansa · Other
Who this trial is looking for
This trial is looking for people with maturity-onset diabetes of the young (MODY) to learn about the effects of a diabetes medication called liraglutide. Participants will take this drug and help researchers understand how it affects their metabolism and digestive issues.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with MODY via genetic testing
- My HgbA1c is over 6.5%
You may not be able to join if
- I have a history of severe allergic reactions to GLP-1 receptor agonists
- I am currently taking GLP-1 receptor agonists
- I take medications in the stimulant class
- I have had bariatric surgery
- I have a personal or family history of medullary thyroid cancer
- I have a personal history of pancreatitis
- I have active kidney disease
- My HbA1c is above 10.0%
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The reason for this research study is to better understand the use of liraglutide, a commonly prescribed Type 2 diabetes medication, in patients with a diagnosis of maturity-onset diabetes of the young (MODY).
The investigators are interested in better understanding the way that this drug affects the metabolism and hormone levels of a person with MODY. Many people with MODY report having gastroin…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of MODY via genetic testing
* HgbA1c \>6.5%
Exclusion Criteria:
* History of anaphylaxis to GLP-1 receptor agonists
* Already taking GLP-1 receptor agonists
* on medications within the stimulant class
* have had bariatric surgery
* personal or family history of can…
Contacts